CDG Invest Growth, a leading Morocco based private equity firm, invests in Soludia Maghreb, the leading provider of haemodialysis products and other related drugs in Morocco, through the acquisition of a significant minority stake.
Founded in 1998 by Dr Abdelaziz Razkaoui after a successful technology transfer from Soludia France, Soludia Maghreb has become a leader in the furniture of Haemodialysis products across the country. Since inception, Soludia Maghreb focused on developing new formulas to enhance the quality of care for haemodialysis patients and delivering a high-end service for private and public care centers. More recently, the company made a $15m investment to build and equip a second first-class manufacturing plant to increase the production capacity, meet the increasing demand both in Morocco and abroad and continue to impact positively the communities it serves.
This is the first investment of CAPMEZZANINE III, the newly raised $100m CIG fund.
Click here for more information about Soludia Maghreb
